Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL). - Shi, Q.; Schmitz, N.; Ou, F. S.; Dixon, J. G.; Cunningham, D.; Pfreundschuh, M.; Seymour, J. F.; Jaeger, U.; Habermann, T. M.; Haioun, C.; Tilly, H.; Ghesquieres, H.; et al. (J Clin Oncol, 2018)